A laparoscopic nephrectomy involves the removal of one kidney through a series of small incisions with a special tool called a laparoscope. It’s an option to treat kidney cancer and other conditions ...

Cytoreductive nephrectomy is a surgical procedure to remove all or part of your kidney to treat cancer that has spread to distant locations. “Cytoreductive” surgeries are procedures that reduce the ...

1. Which doctor should I consult for undergoing nephrectomy? You should consult a surgeon such as an Urologist. 2. Why should I have a kidney removed? You might have your kidney removed if it is ...

PN and RFA offer similar survival for cT1a RCC tumors ≤2 cm, but PN is superior for larger tumors. RFA may be considered for elderly patients with comorbidities, especially for tumors ≤2 cm. PN ...

Maintenance low-dose chemotherapy in patients with high-risk (HR) rhabdomyosarcoma (RMS): A report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Pembrolizumab (pembro) versus ...

Warm ischaemia time (WIT) is seemingly the sole variable that surgeons strive to address in minimizing loss of renal function after partial nephrectomy The term 'zero ischaemia' partial nephrectomy ...

a Mean creatinine after 10 years of follow-up. b Median creatinine after median 24 months of follow-up. NR, not reported. Nephron-sparing surgery (NSS) for renal cell carcinoma has the advantage of ...

Experts recently developed 23 consensus practice points/statements regarding the use of nephrectomy in autosomal dominant polycystic kidney disease (ADPKD). Regardless of when it was performed in ...

Kidney removal surgery, a nephrectomy, can cause pain. While most discomfort fades in weeks, some patients experience chronic pain. Understanding different pain types like flank, back, and nerve pain ...

Patients with renal-cell carcinoma who undergo nephrectomy have no options for adjuvant therapy to reduce the risk of recurrence that have high levels of supporting evidence. In a double-blind, phase ...

Efficacy, safety, and biomarker analysis of neoadjuvant avelumab/axitinib in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after nephrectomy (NeoAvAx). This ...